Skip to content

Latest edition: Monday, November 9, 2026, 10:16 am

General information, not personal advice

BAS.DE■ NeutralNov 9UCG.MI■ NeutralNov 9VLA.PA■ NeutralNov 9VIRI.PA■ NeutralNov 8
Carnet de Séance

Les sociétés cotées, chaque jour au plus fort de la séance

Ratings over the last 30 days: 0 positive, 4 neutral, 0 negative

DSFIR.AS

DSM-Firmenich raised its targets on 4 November 2026 after a stronger third quarter

On 4 November 2026, DSM-Firmenich announced upgraded targets following a third quarter of growth, according to La Télé. The detailed figures were not available in the information consulted.

By Yvan T., published

Illustration. Photo: jarmoluk / Pixabay

The facts

According to La Télé, in a publication of 4 November 2026 at 11:12, DSM-Firmenich raised its targets. The outlet links this decision to growth recorded in the third quarter.

The available information is limited to this headline. It does not specify which measure grew (revenue, earnings, margin), the size of the increase, the new targets, or the share price reaction. None of these elements is therefore reported here.

Our take

This section reflects my own analysis. A target upgrade is generally a favourable signal, as management stakes its credibility on more ambitious forecasts. But without the figures, it is impossible to know whether the upgrade is modest or substantial, or whether it was already anticipated by the market.

Context is also missing: the starting level of the targets, the quality of growth (organic or not), and the weight of currency or scope effects. These points determine the real significance of the announcement.

In these circumstances, I am not forming a firm opinion on DSM-Firmenich and I am not proposing a target price. A quantified target would require earnings, valuation and forecast data that the sources consulted do not provide.

Risks to watch

The analysis rests on a single press headline, with no figures or details. The upgrade may already be priced in, or may rely on one-off items. The full content of the group's press release could qualify this initial assessment.

Sources

  1. DSM-Firmenich relève ses objectifs après une hausse au troisième trimestre (La Télé, 04/11/2026 11:12)

Information from these sources is summarised and rewritten. It has not been independently verified beyond cross-checking between sources; where the reliability of a piece of information is in doubt, the article says so.

Transparency

  • Author
    To be completed, Founder and author of the site, private investor.
  • Conflicts of interest
    On the publication date, holds no position in DSM-Firmenich. The site receives no payment from the companies it covers. The author refrains from any transaction in a stock covered 24 hours before and 48 hours after publication.
  • Method
    Compilation of public information dated November 4, 2026 (sources listed above). The facts reported are kept separate from the analysis, which expresses the author's view. Full methodology.
  • Artificial intelligence
    Text written with an artificial intelligence tool from the sources cited and published automatically, without prior human review.
  • History

General information, not personalised investment advice: this article does not take your situation into account. Investing in shares carries a risk of capital loss. Past performance is not a reliable indicator of future performance. Read the full risk warning.